Outvid vs GAN.AI for Biotech & Pharma
See how Outvid's AI-powered video outreach compares to GAN.AI for reaching r&d directors in Biotech & Pharma. Personalized video at scale vs manual recording.
41%
Reduction in time to first substantive conversation
49%
Higher response rate from research directors
3x
Higher reply rates vs text-only
Part of the modern revenue stack
Biotech & Pharma sales teams face unique challenges like regulatory complexity slows every decision. The typical audience — R&D directors, Clinical ops leaders, Pharma procurement — responds best to personalized, relevant outreach via Email and LinkedIn and Medical conferences. In this landscape, the choice between Outvid and GAN.AI comes down to whether you need scalable AI personalization or manual recording workflows.
How does Outvid compare to GAN.AI for Biotech & Pharma teams?
| Feature | Outvid | GAN.AI |
|---|---|---|
Voice cloning Both clone your voice to speak each personalized script | ||
Deep per-prospect sales research written into the script Outvid researches each prospect and writes the script from live signals; GAN.AI personalizes from data fields for campaign volume, not per-prospect sales research | ||
Personalized landing page per recipient Both generate a per-recipient landing page; Outvid's includes prospect and company intel for sales | ||
Record once, generate a unique video per prospect Both turn a single recording into a personalized video per recipient using an AI clone and voice cloning | ||
Reply detection, branching, and meeting booking Outvid handles replies and books meetings; GAN.AI is a video-generation layer, not an outbound engine | ||
Built for B2B outbound sales Outvid is purpose-built for sales prospecting; GAN.AI leads with brand and marketing campaigns at scale | ||
Multilingual video Both support a wide range of languages via voice cloning |
Why Biotech & Pharma teams switch to Outvid
Built for outbound, not brand campaigns
GAN.AI shines at large marketing sends. Outvid is built for sales: it researches each prospect, writes a script about their situation, and runs the sequence that books the meeting. In Biotech & Pharma, this matters because scientific buyers demand technical credibility upfront.
It runs the outreach, not just the render
GAN.AI hands you personalized videos to deliver through your own stack. Outvid's on-camera persona sends across every channel and handles the follow-up itself. In Biotech & Pharma, this matters because regulatory complexity slows every decision.
Research-driven, one prospect at a time
Personalizing from a spreadsheet column is built for volume. Outvid reads each prospect's role, news, and signals so the message is actually about them. In Biotech & Pharma, this matters because therapeutic area specificity is non-negotiable.
Why is Outvid the better fit for Biotech & Pharma outreach?
Multi-Stakeholder Lab Outreach
Reach the Research Director, VP of Operations, and Procurement Head simultaneously with coordinated video messages tailored to each stakeholder's scientific and operational perspective.
AI clone That Projects Scientific Authority
Record once with your most credible scientific sales professional. Your avatar carries that expertise and gravitas to every prospect interaction, establishing the technical trust that life sciences buyers require before agreeing to a meeting.
Therapeutic Area-Specific Personalization
Generate videos that reference each prospect's disease focus, clinical trial stage, modality, and research infrastructure. A researched, personalized message to an mRNA oncology team looks nothing like one sent to a rare disease biologics group.
Common questions
How does Outvid compare to GAN.AI for Biotech & Pharma?+
For Biotech & Pharma teams, Outvid offers AI-generated personalized video at scale — each prospect gets a unique video with industry-specific research. GAN.AI requires manual recording, which limits how many r&d directors you can reach per day.
Why do Biotech & Pharma teams switch from GAN.AI to Outvid?+
Biotech & Pharma sales teams need to reach r&d directors with messages that reference their specific challenges. Outvid's AI researches each prospect and generates personalized scripts automatically, while GAN.AI relies on manual effort that doesn't scale.
Can Outvid handle Biotech & Pharma-specific outreach better than GAN.AI?+
Yes. Outvid enriches each prospect with industry-specific data — company news, hiring signals, funding rounds — and writes scripts that address Biotech & Pharma pain points like regulatory complexity slows every decision. GAN.AI leaves this research and scripting to you.
What results do Biotech & Pharma teams see with Outvid vs GAN.AI?+
Biotech & Pharma teams using Outvid typically see 2-3x higher reply rates compared to text-only outreach or manually recorded videos. The AI personalization means every prospect feels like you spent 10 minutes researching them — even when you've reached hundreds.
Is it easy to switch from GAN.AI to Outvid for Biotech & Pharma outreach?+
Very easy. Create your AI clone in 2 minutes, import your Biotech & Pharma prospect list, and launch your first campaign in under 15 minutes. No complex migration needed — just a better way to reach r&d directors.
Ready to outperform GAN.AI in Biotech & Pharma?
Book a 20-minute walkthrough with your prospect data.